BACTERIAL VAGINOSIS
Clinical trials for BACTERIAL VAGINOSIS explained in plain language.
Never miss a new study
Get alerted when new BACTERIAL VAGINOSIS trials appear
Sign up with your email to follow new studies for BACTERIAL VAGINOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New bacterial vaginosis drug passes first safety check in healthy volunteers
Disease control Not yet recruitingThis early-stage trial tests a new drug called GenSci142 in 30 healthy Chinese women to see if it is safe and how the body processes it. Participants receive a single dose of the drug or a placebo, and are monitored for side effects for 15 days. The goal is to gather safety infor…
Matched conditions: BACTERIAL VAGINOSIS
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC
-
New combo therapy aims to end recurring BV
Prevention Not yet recruitingThis study tests whether taking BPR-101 capsules along with standard antibiotic treatment can prevent bacterial vaginosis (BV) from returning. About 80 women with BV will receive either the study drug or a placebo. The goal is to see if the combination reduces the chance of BV co…
Matched conditions: BACTERIAL VAGINOSIS
Phase: PHASE2 • Sponsor: Chengdu Syncor Pharmaceutical Co., Ltd. • Aim: Prevention
Last updated Jun 15, 2026 19:02 UTC
-
Probiotic breakthrough: new study aims to stop recurring vaginal infections
Prevention Not yet recruitingThis study tests whether taking a daily probiotic pill (Lactobacillus gasseri) can prevent bacterial vaginosis (BV) from returning after standard antibiotic treatment. BV is a common vaginal infection that often comes back, causing discomfort and discharge. The trial will involve…
Matched conditions: BACTERIAL VAGINOSIS
Phase: PHASE2, PHASE3 • Sponsor: Kaneka Americas Holding Inc. • Aim: Prevention
Last updated Jun 11, 2026 12:11 UTC